LEX-CD8086 transfers its intrinsic LAA and molecules and acquired costimulatory CD80 and CD86 molecules to CD4+ T cells, making CD4+ TLEX-CD8086 cells both Th1 cells and APCs capable of inducing efficient leukemia antigen-specific CD8+ CTL response. This evidence concerns the gene CD80 and leukemia.